Learn more

LUNAN BETTER PHARMACEUTICAL CO LTD

Overview
  • Total Patents
    38
  • GoodIP Patent Rank
    69,493
About

LUNAN BETTER PHARMACEUTICAL CO LTD has a total of 38 patent applications. Its first patent ever was published in 2010. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are SUZHOU TERUI PHARMACEUTICAL CO LTD, CHEMO RES S L and SHENZHEN SALUBRIS PHARM CO LTD.

Patent filings per year

Chart showing LUNAN BETTER PHARMACEUTICAL CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Zhang Guimin 17
#2 Zhao Zhiquan 16
#3 Hao Guizhou 4
#4 Chen Xiaowei 2
#5 Dong Qisong 2
#6 Ren Ying 2
#7 Guo Yanling 2
#8 Wang Xiujuan 2
#9 Ma Yongjie 2
#10 Yang Bin 2

Latest patents

Publication Filing date Title
CN112174975A Green refining method of isosorbide mononitrate
WO2021077242A1 Caspofungin synthesis method and intermediate thereof
WO2021072774A1 Method for synthesizing sevoflurane
WO2021042278A1 Multi-unit sustained-release acipimox pellet tablet and preparation method therefor
CN105663124A Histamine dihydrochloride injection and preparation method thereof
CN105687132A Concentrated solution for temsirolimus injection and preparation method thereof
CN105541786A Montelukast side chain intermediate and preparing method thereof
CN105456213A Montelukast sodium tablet
CN105457033A Compound chlorzoxazone tablet
CN105395503A Compound chlorzoxazone dispersible tablet
CN105030691A Loratadine granules
CN105030708A Riluzole tablets and preparation method thereof
CN104997736A Aniracetam particle
CN104940135A Fluconazole injection and preparation method thereof
CN104940157A Aceclofenac enteric-coated tablet and preparing method thereof
CN104873478A Tamsulosin hydrochloride sustained-release capsule and preparation method thereof
CN104784135A Finasteride tablets
CN104771378A Simvastatin tablet
CN104622825A Azithromycin dispersible tablet
CN104546772A Cetirizine hydrochloride tablet